Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Funding This work was supported by Japan Agency for Medical Research and Development (AMED) (23ama221520h0001 to K.S.), a Grant-in-Aid for Scientific Research (B) 20H03668, BRIDGE (programs for bridging the gap between R&D and the ideal society (Society 5.0 to RH and KS) and generating economic and social value to K.S.), the National Cancer Center Research and Development Fund (2022-A-20, 2023-J-2, NCC Biobank, and NCC Core Facility to K.S.), and the Yamagata Prefectural Government and City of Tsuruoka (HM)
In summary, current clinical data confirms that NAC is a safe adjunctive therapy with a minimal risk of severe adverse effects for chronic respiratory conditions
Some evidence suggests that individuals with impaired glucose tolerance may exhibit different GLP-1 responses to dietary stimuli compared to metabolically healthy individuals, though specific data regarding allulose in this context remain limited
Both telogen effluvium and unmasking of androgenic alopecia are possible
)
Reaching for high-hanging fruit in drug discovery at proteinprotein interfaces
US$ 21.51
US$ 29.20
US$ 24.66
US$ 22.84
US$ 26.84
US$ 25.72
US$ 22.76
